Showing 1,741 - 1,760 results of 3,149 for search '"breast"', query time: 0.08s Refine Results
  1. 1741
  2. 1742
  3. 1743
  4. 1744
  5. 1745
  6. 1746
  7. 1747
  8. 1748
  9. 1749
  10. 1750
  11. 1751
  12. 1752
  13. 1753
  14. 1754

    Global elective breast- and colorectal cancer surgery performance backlogs, attributable mortality and implemented health system responses during the COVID-19 pandemic: A scoping review. by Sonia Haribhai, Komal Bhatia, Maryam Shahmanesh

    Published 2023-01-01
    “…This study evaluated the impact of the COVID-19 pandemic on elective breast- or colorectal cancer (CRC) procedure backlogs and attributable mortality, globally. …”
    Get full text
    Article
  15. 1755
  16. 1756

    Matrine Inhibits Breast Cancer Cell Proliferation and Epithelial-Mesenchymal Transition Through Regulating the LINC01116/miR-9-5p/ITGB1 Axis by Lili Ren, Ziru Fang, Jiaojiao Xu, Xiaoxiao Wu, Yongjun Zhang, Hu Cai, Zhicun Han

    Published 2025-01-01
    “…Background: Breast cancer (BC) is the most prevalent solid cancer affecting women’s health globally. …”
    Get full text
    Article
  17. 1757

    Evaluation of the a-amylase enzyme, Carbohydrate Antigen CA-15.3 ( C.A 15.3),and some biochemical variables in the blood serum of breast cancer patients by Nagham abd, Ebtehal Sabri Mohammed, Amer Fadel Dawood

    Published 2025-01-01
    “… Evaluation of the amylase enzyme and some biochemical variables in the serum of breast cancer patients for all stages of the disease in patients compared to healthy women. …”
    Get full text
    Article
  18. 1758

    GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth by Ana Alvarez de Cienfuegos, Lawrence H Cheung, Khalid A Mohamedali, Michael G Rosenblum, Brian Aguirre, Cheng-Hsiang Lu, Anubhav Chandla, Nidhi Kejriwal, Lucia Liu, Ann M Chan, SuYin Kok, Sergio Duarte, David Casero, Madhuri Wadehra

    Published 2024-12-01
    “…Epithelial membrane protein-2 (EMP2) is highly expressed in invasive breast cancer (BC), including triple-negative BC (TNBC), and represents an attractive therapeutic target.Methods We designed a novel fusion protein (GrB-Fc-KS49) composed of an active GrB fused to an anti-EMP2 single-chain antibody tethered through the immunoglobulin G heavy chain (Fc) domain. …”
    Get full text
    Article
  19. 1759
  20. 1760